JP Morgan Chase
ROIV icon

JP Morgan Chase’s Roivant Sciences ROIV Stock Holding History

JP Morgan Chase’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$40.3M Sell
1,137,867
-399,652
-26% -$11.8M ﹤0.01% 1635
2026
Q1 		$40.6M Buy
1,537,519
+602,986
+65% +$15.5M ﹤0.01% 1519
2025
Q4 		$20.3M Sell
934,533
-294,664
-24% -$5.81M ﹤0.01% 2059
2025
Q3 		$18.6M Buy
1,229,197
+445,270
+57% +$5.51M ﹤0.01% 2160
2025
Q2 		$8.83M Sell
783,927
-23,838
-3% -$258K ﹤0.01% 2668
2025
Q1 		$8.15M Buy
807,765
+39,276
+5% +$425K ﹤0.01% 2726
2024
Q4 		$9.09M Sell
768,489
-54,093
-7% -$640K ﹤0.01% 2779
2024
Q3 		$9.49M Buy
822,582
+34,453
+4% +$392K ﹤0.01% 2651
2024
Q2 		$8.33M Sell
788,129
-135,673
-15% -$1.49M ﹤0.01% 2609
2024
Q1 		$9.74M Buy
923,802
+501,362
+119% +$5.41M ﹤0.01% 2512
2023
Q4 		$4.74M Sell
422,440
-146,680
-26% -$1.43M ﹤0.01% 3144
2023
Q3 		$6.65M Buy
569,120
+238,303
+72% +$2.69M ﹤0.01% 2624
2023
Q2 		$3.33M Sell
330,817
-9,941
-3% -$88.9K ﹤0.01% 3170
2023
Q1 		$2.51M Buy
340,758
+266,464
+359% +$2.19M ﹤0.01% 3375
2022
Q4 		$593K Buy
74,294
+33,534
+82% +$187K ﹤0.01% 4404
2022
Q3 		$131K Buy
40,760
+2,866
+8% +$11.1K ﹤0.01% 5164
2022
Q2 		$154K Buy
+37,894
New +$150K ﹤0.01% 5204

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

JP Morgan Chase's ROIV Position: Q2 2026 in Review

JP Morgan Chase reduced its Roivant Sciences (ROIV) stake by 26% in Q2 2026, selling an estimated $11.8M and leaving 1,137,867 shares worth $40.3M. The position accounts for ﹤0.01% of the portfolio, ranked #1635.

JP Morgan Chase first reported a position in ROIV in Q2 2022 and has held it in 17 quarters since. The position peaked at $40.6M in Q1 2026. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • JP Morgan Chase held 1,137,867 shares of Roivant Sciences worth $40.3M as of Q2 2026.
  • JP Morgan Chase sold 399,652 Roivant Sciences shares in Q2 2026, an estimated $11.8M.
  • Roivant Sciences made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #1635 holding.
  • JP Morgan Chase first reported a position in Roivant Sciences in Q2 2022 and has held it in 17 quarters since.
  • JP Morgan Chase's Roivant Sciences position peaked at $40.6M in Q1 2026.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.